Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Acetylation status using hydralazine in African hypertensives at Kenyatta National Hospital.

East African medical journal - 1 Jul 1992

Rashid J R, Kofi-Tsepko, Juma F D

Abstract excerpt

In this study, the investigation of hydralazine acetylator phenotype was undertaken for the first time in African hypertensives at Kenyatta National Hospital. A total of 25 randomly selected patients with moderate to severe hypertension (diastolic pressure 105-130 mmHg), participated in the phenotyping study. The phenotyping was done by administering oral standard hydralazine dose of 150 mg/day in three divided...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acetylation
Share to Administration, Oral
Share to Aged

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Arylamine N-Acetyltransferase

Share to Gene Frequency

Share to Hypertension

Share to Phenotype

Source

Identifiers

PMID: 1396201

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Acetylation status using hydralazine in African hypertensives at Kenyatta National Hospital.PMID 1396201Read ↗

Genotype-Guided Hydralazine TherapySemantic proximity Read ↗

Acetylation phenotype in hypertensive patients.Semantic proximity Read ↗

Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy.Semantic proximity Read ↗

Different phenotypes of the NAT2 gene influences hydralazine antihypertensive response in patients with resistant hypertension.Semantic proximity Read ↗

Plasma concentration and acetylator phenotype determine response to oral hydralazine.Semantic proximity Read ↗

Pharmacokinetics of hydralazine, an antihypertensive and DNA-demethylating agent, using controlled-release formulations designed for use in dosing schedules based on the acetylator phenotype.Semantic proximity Read ↗

N-Acetyltransferase 2 Genotype-Dependent N-Acetylation of Hydralazine in Human Hepatocytes.Semantic proximity Read ↗

An assessment of acetylator polymorphism and its relevance in Papua New Guinea.Semantic proximity Read ↗

Isoniazid acetylation phenotyping in Saudi Arabs.Semantic proximity Read ↗

N-acetylation phenotyping with sulphadimidine in a Turkish population.Semantic proximity Read ↗

Studies on N-Acetyltransferase (NAT2) Genotype Relationships in Emiratis: Confirmation of the Existence of Phenotype Variation among Slow Acetylators.Semantic proximity Read ↗

Possible optimization of sulphadimidine dosage for acetylator phenotyping.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.